# Xtrackers IE Plc - MSCI Genomic Healthcare Innov UCITS ETF (XGES)

**Source:** https://fundology.uk/fund/xges · ISIN IE000KD0BZ68 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 30/09/2026, XGES (MSCI Genomic Healthcare Innov UCITS ETF, ISIN IE000KD0BZ68) closed at £34.13 on the London Stock Exchange. Its ongoing charge is 0.36% a year (about £36 on £10,000). Over the three years to 30/09/2026 its total return was +46.5%, or +32.2% after UK CPIH inflation.

## Summary

Xtrackers IE Plc - MSCI Genomic Healthcare Innov UCITS ETF is an exchange-traded fund (ETF) from Xtrackers, launched in 2022. It tracks the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100 Index - Benchmark TR Net — large and medium-sized companies across developed and emerging markets. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.36% a year — about £36 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£34.13** (30/09/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | XGES |
| ISIN | IE000KD0BZ68 |
| Category | Technology |
| Type | ETF |
| Provider | Xtrackers |
| Tracks | MSCI ACWI IMI Genomic Innovation Select ESG Screened 100 Index - Benchmark TR Net |
| Income | Accumulating |
| Ongoing charge | 0.36% a year (£36 per £10,000) |
| Fund size | £6.8m |
| Launched | 2022 |
| Domicile | Ireland |

## Past returns (periods to 30/09/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +50.50% | +45.78% | income reinvested |
| 3 years | +46.55% | +32.24% | income reinvested |

Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published.

## Charges compared with similar funds

Ongoing charge of Xtrackers IE Plc - MSCI Genomic Healthcare Innov UCITS ETF 0.36% a year, as of 01/10/2026: 91 of the 118 other technology funds charge more, 0 the same and 27 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.36%** per year
- ISA eligible: yes
- SIPP eligible: yes

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.